Malaria Journal (Oct 2010)
A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of <it>Plasmodium falciparum</it>
Abstract
No abstracts available.
Malaria Journal (Oct 2010)